Drug Licence Questions Arise for India's Online Pharmacies

India's drug licensing laws, originally conceived for neighborhood chemist shops, are facing significant challenges in the era of online pharmacies. A typical online medicine order might appear as a single transaction to a consumer, but legally, it can involve up to four distinct entities: a licensed seller, a marketplace platform, a warehouse, and a delivery operator. The current legal framework, predating widespread e-commerce, struggles to assign responsibility and licensing requirements in these multi-party digital supply chains.

This ambiguity recently led to action by the Karnataka Food Safety and Drug Administration, which seized medicines from two facilities linked to Amazon in September. The agency cited the lack of a drug licence for storing the medications, raising a critical question: when inventory is owned by one entity and stored by another, who is responsible for obtaining the licence? The answer to this question is crucial for determining accountability in cases of improper storage, sale without prescription, or counterfeit drugs.

The Drugs and Cosmetics Act of 1940 and its subsequent rules from 1945 mandate that any entity selling, stocking, or distributing drugs must hold a specific licence tied to particular premises and overseen by a qualified pharmacist. This structure assumes a single entity manages all aspects of the sale, a model that often does not apply to online pharmacy operations where functions are frequently outsourced or handled by separate specialized companies.

Attempts to update the regulations have been insufficient. A draft set of rules for e-pharmacies was published by the Ministry of Health in 2018 but was never formally notified. Consequently, online medicine sales continue to operate under a framework designed for brick-and-mortar establishments, with courts often called upon to interpret the law in new contexts. Litigation between online platforms and regulatory bodies, such as the Central Drugs Standard Control Organisation (CDSCO), has been ongoing.

MediaNama has sought clarification from both the Karnataka FDA and the CDSCO regarding the licensing requirements for entities storing drugs owned by third-party sellers. As of now, no definitive response has been provided, and applications filed under the Right to Information Act are pending. This lack of clear regulatory guidance leaves the operational landscape for online pharmacies uncertain and potentially vulnerable to further enforcement actions.